Zhitong Finance App News, Shengnuo Biotech (688117.SH) announced that Chengdu Shengnuo Biopharmaceutical Co., Ltd. (hereinafter referred to as “Shengnuo Pharmaceutical”), a wholly-owned subsidiary of the company, underwent on-site inspections by the US Food and Drug Administration (“FDA”) inspection team from August 20, 2026 to August 22, 2026, and August 27, 2026.
智通财经·09/22/2026 04:33:01
语音播报
Zhitong Finance App News, Shengnuo Biotech (688117.SH) announced that Chengdu Shengnuo Biopharmaceutical Co., Ltd. (hereinafter referred to as “Shengnuo Pharmaceutical”), a wholly-owned subsidiary of the company, underwent on-site inspections by the US Food and Drug Administration (“FDA”) inspection team from August 20, 2026 to August 22, 2026, and August 27, 2026.